-
公开(公告)号:US20120115870A1
公开(公告)日:2012-05-10
申请号:US13348376
申请日:2012-01-11
申请人: Debra L. Fleenor , Iok-Hou Pang , Allan R. Shepard , Mark R. Hellberg , Peter G. Klimko , Abbot F. Clark
发明人: Debra L. Fleenor , Iok-Hou Pang , Allan R. Shepard , Mark R. Hellberg , Peter G. Klimko , Abbot F. Clark
IPC分类号: A61K31/5377 , C07D401/14 , A61K31/4439 , A61K31/437 , C07D471/04 , A61P27/02 , A61K31/506 , A61P27/06 , A61K31/519 , C07D417/12 , A61K31/495 , C07D413/12 , C07D413/14 , C12Q1/02 , C07D405/14
CPC分类号: G01N33/5008 , A61K31/357 , A61K31/381 , A61K31/4192 , A61K31/4196 , A61K31/44 , A61K31/4439 , A61K31/444 , A61K31/47 , A61K31/4709 , A61K31/4745 , A61K31/506 , A61K31/519 , A61K31/5375 , A61K31/5377 , A61K45/06 , G01N33/5023 , G01N33/5044 , A61K2300/00
摘要: An ophthalmic pharmaceutical composition useful in the treatment of glaucoma and control of intraocular pressure comprising an effective amount of a selective modulator of ALK5 receptor activity is disclosed. Also disclosed is a method of treating glaucoma and controlling intraocular pressure comprising applying a therapeutically effective amount of a pharmaceutical composition comprising a selective modulator of ALK5 receptor activity to an affected eye of a patient.
摘要翻译: 公开了一种可用于治疗青光眼和控制眼内压的眼用药物组合物,其包含有效量的ALK5受体活性的选择性调节剂。 还公开了一种治疗青光眼并控制眼内压的方法,其包括将治疗有效量的包含ALK5受体活性的选择性调节剂的药物组合物施用于患者的受影响的眼睛。
-
2.Superoxide dismutase mimics for the treatment of ocular disorders and diseases 有权
标题翻译: 超氧化物歧化酶用于治疗眼部疾病和疾病公开(公告)号:US08003635B2
公开(公告)日:2011-08-23
申请号:US12766332
申请日:2010-04-23
IPC分类号: A61K31/555
CPC分类号: A61K31/555 , Y10S514/912
摘要: The use of SOD mimics particularly pentaazacycle Mn(II) complex SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
摘要翻译: 公开了使用SOD模拟,特别是五唑环Mn(II)复合物SOD模拟物,用于治疗AMD,DR和视网膜水肿。
-
公开(公告)号:US06645978B1
公开(公告)日:2003-11-11
申请号:US09787789
申请日:2001-03-23
IPC分类号: A61K900
CPC分类号: A61K31/202 , A61K9/0048 , A61K31/557 , Y10S514/822 , Y10S514/925 , Y10S514/947 , Y10S514/954
摘要: Ophthalmic compositions containing Lipoxin A4 and its analogs and methods of their use for treating dry eve are disclosed.
摘要翻译: 公开了含有Lipoxin A4及其类似物的眼科组合物及其用于治疗干燥前夕的方法。
-
4.
公开(公告)号:US06552084B2
公开(公告)日:2003-04-22
申请号:US09950457
申请日:2001-09-10
IPC分类号: A01N3710
CPC分类号: C07C59/42 , C07C59/46 , C07C2601/02
摘要: Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders are disclosed.
-
5.OPHTHALMIC COMPOSITION WITH NITRIC OXIDE DONOR COMPOUND AND METHOD OF FORMING AND USING SAME 审中-公开
标题翻译: 具有氧化氮化合物的透明组合物及其形成和使用方法公开(公告)号:US20140371267A1
公开(公告)日:2014-12-18
申请号:US14471746
申请日:2014-08-28
IPC分类号: C07D211/94
CPC分类号: C07D211/94 , A61K31/4015 , A61K31/4468 , A61K31/454 , A61K31/496
摘要: The present invention is directed to the provision of ophthalmic compositions such as multi-dose, topical, ophthalmic compositions. The compositions include a nitric oxide (NO) donor compound.
摘要翻译: 本发明涉及提供眼用组合物,例如多剂量,局部,眼用组合物。 组合物包括一氧化氮(NO)供体化合物。
-
公开(公告)号:US07112588B2
公开(公告)日:2006-09-26
申请号:US10808061
申请日:2004-03-24
申请人: Peter G. Klimko , Mark R. Hellberg
发明人: Peter G. Klimko , Mark R. Hellberg
IPC分类号: A61K31/495
CPC分类号: A61K31/407 , A61K31/4015 , Y10S514/912
摘要: Proteasome inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
-
公开(公告)号:US06740674B2
公开(公告)日:2004-05-25
申请号:US10150191
申请日:2002-05-17
申请人: Peter G. Klimko , Mark R. Hellberg
发明人: Peter G. Klimko , Mark R. Hellberg
IPC分类号: A61K3146
CPC分类号: A61K31/4015 , A61K31/407 , Y10S514/912
摘要: Proteasome inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
摘要翻译: 蛋白酶体抑制剂可用于治疗干眼病和其它需要润湿眼睛的疾病。
-
8.15-ketal postaglandins for the treatment of glaucoma or ocular hypertension 失效
标题翻译: 15-ketal postaglandins用于治疗青光眼或高眼压症公开(公告)号:US06353014B1
公开(公告)日:2002-03-05
申请号:US09284534
申请日:1999-06-02
IPC分类号: A01N4338
CPC分类号: A61K31/5575 , A61K31/5585
摘要: A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:
摘要翻译: 一种治疗患者的青光眼或高眼压症的方法,其包括向患者施用药学有效量的式I化合物:
-
9.11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension 失效
标题翻译: 用于治疗青光眼和高眼压症的11-Aza前列腺素公开(公告)号:US06211226B1
公开(公告)日:2001-04-03
申请号:US09430533
申请日:1999-10-29
申请人: Mark R. Hellberg , Peter G. Klimko
发明人: Mark R. Hellberg , Peter G. Klimko
IPC分类号: A61K3140
CPC分类号: C07D207/12 , A61K31/40
摘要: 11-aza analogs of PGF2&agr; and methods of their use in treating glaucoma and ocular hypertension are disclosed.
摘要翻译: 公开了PGF2α的11-氮杂类似物及其用于治疗青光眼和高眼压症的方法。
-
10.Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension 失效
标题翻译: 使用某些前列腺素类似物治疗青光眼和高眼压症公开(公告)号:US5807892A
公开(公告)日:1998-09-15
申请号:US480706
申请日:1995-06-07
IPC分类号: A61K31/557 , A61K31/5575 , C07C405/00 , A61K31/695 , A61K31/35 , C07C177/00
CPC分类号: A61K31/5575 , A61K31/557 , C07C405/0016
摘要: Certain prostaglandin analogues are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandin analogues.
摘要翻译: 某些前列腺素类似物可用于治疗青光眼和高眼压症。 还公开了包含这种前列腺素类似物的眼科药物组合物。
-
-
-
-
-
-
-
-
-